Protein Thought to Promote Cancer Does Opposite
TOOLBOX   Resize
 Save/Share +
COMMENT
 Discussion Policy
 CLOSE
Comments that include profanity or personal attacks or other inappropriate comments or material will be removed from the site. Additionally, entries that are unsigned or contain "signatures" by someone other than the actual author will be removed. Finally, we will take steps to block users who violate any of our posting standards, terms of use or privacy policies or any other policies governing this site. Please review the full rules governing commentaries and discussions. You are fully responsible for the content that you post.
|
FRIDAY, July 11 (HealthDay News) -- A protein that appears to suppress the growth of human cancer cells in lab cultures was, until recently, thought topromotecolorectal cancer.
Previous animal studies have found that a gene called TCF7L2 is active in about 90 percent of colorectal cancers because of a biochemical malfunction in a gene. As a result, researchers suspected TCF7L2 triggered colorectal cancer in humans.
New technology used by University of Texas Southwestern Medical Center at Dallas researchers, however, allowed them to study the gene on human colorectal cancer cells. When the researchers switched off the TCF7L2 gene, human colorectal cancer cells actually grew stronger and more rapidly in lab cultures.
"This finding reshapes a fundamental model of how colorectal cancer arises," senior study author Lawrence Lum, an assistant professor of cell biology at UT Southwestern, said in a university news release.
The study was published online in this week's issue of theProceedings of the National Academy of Sciences.
The next step, he said, is to understand more fully all the steps in the biochemical pathway involved in controlling the action of TCF7L2. This may help find new therapeutic targets for treating colorectal cancer.
More information
The American Cancer Society has more about colorectal cancer.
SOURCE: University of Texas Southwestern Medical Center at Dallas, news release, July 7, 2008
